Literature DB >> 31359358

The protective effect of Cordycepin on diabetic nephropathy through autophagy induction in vivo and in vitro.

Tao Cao1, Ricong Xu2, Yi Xu2, Yang Liu2, Dongli Qi2, Qijun Wan2.   

Abstract

BACKGROUND: Diabetic nephropathy (DN) is one of the most serious chronic complications of diabetes mellitus (DM). Autophagy is an important physiological function for podocytes to maintain stability of intracellular environment. In this study, we planned to clarify the effect of Cordycepin, a traditional Chinese medicine, on DN and the related mechanisms.
METHODS: All rats were randomly divided into normal control group, diabetic controls, low-dose group (10 mg/kg), medium-dose group (100 mg/kg), and high-dose group (500 mg/kg). The level of cholesterol, blood sugar, triglyceride, creatinine, and urine protein was examined through an automatic biochemistry analyser. Enzyme-linked immunosorbent assay (Elisa) was used to detect the level of IL-1β, IL-6, and IL-18. HE staining was used to examine histopathologic changes. TUNEL staining was used to detected cell apoptosis. The expression of fibrosis markers α-SMA, t-TG, and TIMP-1, apoptosis-related proteins cleaved-caspase3, Bax and Bcl-2, autophagy markers Beclin1, light chain 3 (LC3)I/II, and p62 were evaluated by western blot.
RESULTS: The level of cholesterol, blood sugar, triglyceride, creatinine, and urine protein in the diabetic controls was much higher than that in the normal control group. Obvious histopathology injuries were also found in DN model group. After Cordycepin treatment, all the above indexes were improved compared with the DN group and tissue damages were also alleviated. Further studies showed that Cordycepin suppressed cell apoptosis and renal fibrosis and rescued cell autophagy in DN rat model. Moreover, the results of our in vitro experiments showed that the addition of 3-methyladenine (3-MA, specific autophagy inhibitor) successfully abolished the protective effect of Cordycepin on renal fibrosis through inducing apoptosis and renal fibrosis. The above protective effects of Cordycepin were exhibited in a dose-dependent manner.
CONCLUSION: Cordycepin participated in the modulation of cell apoptosis, fibrosis, and autophagy induction in DN. Our study for the first time revealed that Cordycepin had a certain therapeutic effect on DN in rats through autophagy induction.

Entities:  

Keywords:  Apoptosis; Autophagy; Cordycepin; Diabetic nephropathy

Mesh:

Substances:

Year:  2019        PMID: 31359358     DOI: 10.1007/s11255-019-02241-y

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  26 in total

1.  Glucose sensing by gut endocrine cells and activation of the vagal afferent pathway is impaired in a rodent model of type 2 diabetes mellitus.

Authors:  Jennifer Lee; Bethany P Cummings; Elizabeth Martin; James W Sharp; James L Graham; Kimber L Stanhope; Peter J Havel; Helen E Raybould
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-12-07       Impact factor: 3.619

2.  Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001.

Authors:  Ali H Mokdad; Earl S Ford; Barbara A Bowman; William H Dietz; Frank Vinicor; Virginia S Bales; James S Marks
Journal:  JAMA       Date:  2003-01-01       Impact factor: 56.272

3.  [Cordycepin protects podocytes from injury mediated by complements complex C5b-9].

Authors:  Tao Hong; Lu-ke Cui; Ji Wen; Ming-hua Zhang; Jun-ming Fan
Journal:  Sichuan Da Xue Xue Bao Yi Xue Ban       Date:  2015-03

4.  Paeoniflorin ameliorates AGEs-induced mesangial cell injury through inhibiting RAGE/mTOR/autophagy pathway.

Authors:  Juan Chen; Di Zhao; Maomao Zhu; Minghua Zhang; Xuefeng Hou; Wenbo Ding; Shuai Sun; Weiquan Bu; Liang Feng; Shiping Ma; Xiaobin Jia
Journal:  Biomed Pharmacother       Date:  2017-03-18       Impact factor: 6.529

5.  Impaired Podocyte Autophagy Exacerbates Proteinuria in Diabetic Nephropathy.

Authors:  Atsuko Tagawa; Mako Yasuda; Shinji Kume; Kosuke Yamahara; Jun Nakazawa; Masami Chin-Kanasaki; Hisazumi Araki; Shin-Ichi Araki; Daisuke Koya; Katsuhiko Asanuma; Eun-Hee Kim; Masakazu Haneda; Nobuyuki Kajiwara; Kazuyuki Hayashi; Hiroshi Ohashi; Satoshi Ugi; Hiroshi Maegawa; Takashi Uzu
Journal:  Diabetes       Date:  2015-09-17       Impact factor: 9.461

6.  The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes.

Authors:  Josephine M Forbes; Vicki Thallas; Merlin C Thomas; Hank W Founds; Wendy C Burns; George Jerums; Mark E Cooper
Journal:  FASEB J       Date:  2003-07-18       Impact factor: 5.191

7.  Cordycepin, a Characteristic Bioactive Constituent in Cordyceps militaris, Ameliorates Hyperuricemia through URAT1 in Hyperuricemic Mice.

Authors:  Tianqiao Yong; Shaodan Chen; Yizhen Xie; Diling Chen; Jiyan Su; Ou Shuai; Chunwei Jiao; Dan Zuo
Journal:  Front Microbiol       Date:  2018-01-25       Impact factor: 5.640

8.  Cordycepin disrupts leukemia association with mesenchymal stromal cells and eliminates leukemia stem cell activity.

Authors:  Shu-Man Liang; Yi-Jhu Lu; Bor-Sheng Ko; Yee-Jee Jan; Song-Kun Shyue; Shaw-Fang Yet; Jun-Yang Liou
Journal:  Sci Rep       Date:  2017-03-07       Impact factor: 4.379

9.  Tripterygium glycoside protects against puromycin amino nucleoside‑induced podocyte injury by upregulating autophagy.

Authors:  Jianguang Gong; Juan Jin; Li Zhao; Yiqiao Li; Yiwen Li; Qiang He
Journal:  Int J Mol Med       Date:  2018-03-29       Impact factor: 4.101

10.  Cordyceps militaris Improves Chronic Kidney Disease by Affecting TLR4/NF-κB Redox Signaling Pathway.

Authors:  Tingli Sun; Wenpeng Dong; Guohong Jiang; Jingbo Yang; Jizhang Liu; Lijie Zhao; Peilong Ma
Journal:  Oxid Med Cell Longev       Date:  2019-03-31       Impact factor: 6.543

View more
  8 in total

1.  Cordycepin Nanoencapsulated in Poly(Lactic-Co-Glycolic Acid) Exhibits Better Cytotoxicity and Lower Hemotoxicity Than Free Drug.

Authors:  Gregory Marslin; Vinoth Khandelwal; Gregory Franklin
Journal:  Nanotechnol Sci Appl       Date:  2020-06-12

2.  Silibinin Augments the Antifibrotic Effect of Valsartan Through Inactivation of TGF-β1 Signaling in Kidney.

Authors:  Ronggui Liu; Qinqin Wang; Zhaoyan Ding; Xiaojuan Zhang; Yunping Li; Yichen Zang; Guijun Zhang
Journal:  Drug Des Devel Ther       Date:  2020-02-13       Impact factor: 4.162

Review 3.  Cell Clearing Systems as Targets of Polyphenols in Viral Infections: Potential Implications for COVID-19 Pathogenesis.

Authors:  Fiona Limanaqi; Carla Letizia Busceti; Francesca Biagioni; Gloria Lazzeri; Maurizio Forte; Sonia Schiavon; Sebastiano Sciarretta; Giacomo Frati; Francesco Fornai
Journal:  Antioxidants (Basel)       Date:  2020-11-10

Review 4.  A Systematic Review of the Biological Effects of Cordycepin.

Authors:  Masar Radhi; Sadaf Ashraf; Steven Lawrence; Asta Arendt Tranholm; Peter Arthur David Wellham; Abdul Hafeez; Ammar Sabah Khamis; Robert Thomas; Daniel McWilliams; Cornelia Huiberdina de Moor
Journal:  Molecules       Date:  2021-09-28       Impact factor: 4.411

Review 5.  Research Progress on Cordycepin Synthesis and Methods for Enhancement of Cordycepin Production in Cordyceps militaris.

Authors:  Li Wang; Huanhuan Yan; Bin Zeng; Zhihong Hu
Journal:  Bioengineering (Basel)       Date:  2022-02-11

6.  Tangshen Decoction Enhances Podocytes Autophagy to Relieve Diabetic Nephropathy through Modulation of p-AMPK/p-ULK1 Signaling.

Authors:  Ling Yan; Xiaoxiao Xu; Yanbo Fan; Lifang Zhang; Xiaojing Niu; Aimin Hu
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-11       Impact factor: 2.650

Review 7.  Cordycepin for Health and Wellbeing: A Potent Bioactive Metabolite of an Entomopathogenic Cordyceps Medicinal Fungus and Its Nutraceutical and Therapeutic Potential.

Authors:  Syed Amir Ashraf; Abd Elmoneim O Elkhalifa; Arif Jamal Siddiqui; Mitesh Patel; Amir Mahgoub Awadelkareem; Mejdi Snoussi; Mohammad Saquib Ashraf; Mohd Adnan; Sibte Hadi
Journal:  Molecules       Date:  2020-06-12       Impact factor: 4.411

8.  Cordycepin Ameliorates Nonalcoholic Steatohepatitis by Activation of the AMP-Activated Protein Kinase Signaling Pathway.

Authors:  Tian Lan; Yang Yu; Jing Zhang; Haonan Li; Qiqing Weng; Shuo Jiang; Song Tian; Tonghao Xu; Sha Hu; Guizhi Yang; Yan Zhang; Weixuan Wang; Lexun Wang; Qing Zhu; Xianglu Rong; Jiao Guo
Journal:  Hepatology       Date:  2021-08       Impact factor: 17.425

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.